The study of phages that pose a threat to the cheese industry, which enabled the original demonstration that CRISPR–Cas systems work as adaptive immune systems in bacteria, now leads to the identification of a new anti-CRISPR that inhibits Cas9 from Streptococcus pyogenes.
This is a preview of subscription content, log in via an institution to check access.
References
Barrangou, R. & Doudna, J. A. Nat. Biotechnol. 34, 933–941 (2016).
Bondy-Denomy, J., Pawluk, A., Maxwell, K. L. & Davidson, A. R. Nature 493, 429–432 (2013).
Sontheimer, E. J. & Davidson, A. R. Curr. Opin. Microbiol. 37, 120–127 (2017).
Hynes, A. P. et al. Nat. Microbiol. http://doi.org/10.1038/s41564-017-0004-7 (2017).
Pawluk, A. et al. Nat. Micrbiol. 1, 16085 (2016).
Pawluk, A. et al. Cell 167, 1829–1838 (2016).
Rauch, B. J. et al. Cell 168, 150–158 (2017).
Barrangou, R. et al. Science 315, 1709–1712 (2007).
Donovan, R. DuPont nutrition & health hurdles the process challenges for pizza cheese. Danisco (3 April 2012).
Building the safe genes toolkit. DARPA (19 July 2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Davidson, A.R. Cheese, phages and anti-CRISPRs. Nat Microbiol 2, 1338–1339 (2017). https://doi.org/10.1038/s41564-017-0026-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41564-017-0026-1
- Springer Nature Limited